Pharmaron is a premier service provider emphasizing the most highly relevant physiological models to further research accuracy from discovery through post-market surveillance. We partner with you to overcome ADMET barrier in the development of drugs and devices to improve human outcomes. Our research covers in vivo, ex vivo, in vitro support from R&D through commercial GMP. Pharmaron provides analytical testing for in vivo and ex vivo gene therapies, cell therapies and immunotherapies, CAR-T, T-Cell – in vitro cell based potency assay development, in vivo biodistribution, toxicology and efficacy. Our services include GMP-compliant gene/cell therapy commercial potency release testing at an FDA/MHRA inspected facility.